Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Noro Psikiyatri Arsivi|January 12, 2018
Validity and Reliability of the Turkish Version for DSM-5 Level 2 Anger Scale (Child Form for Children Aged 11-17 Years and Parent Form for Children Aged 6-17 Years)Şermin Yalin Sapmaz, Handan Özek Erkuran, Nefize Yalin, et al.Journal of Affective Disorders|August 10, 2021
Clinical characteristics and impacts of HIV infection in people with bipolar disordersNefize Yalin, Isabella Conti, Shaun Bagchi, et al.Journal of Affective Disorders|November 27, 2025
Thyroid-stimulating hormone is associated with differential antidepressant and anti-anhedonic response to ketamine in bipolar depression but not major depressive disorderBrady D Greene, Adam Fijtman, Nefize Yalin, et al.Journal of Affective Disorders|December 11, 2019
Unipolar mania: Identification and characterisation of cases in France and the United KingdomPaul R A Stokes, Nefize Yalin, Tim Mantingh, et al.Neuroimage. Clinical|February 10, 2019
Cortical thickness and surface area as an endophenotype in bipolar disorder type I patients and their first-degree relativesNefize Yalin, Aybala Saricicek, Ceren Hidiroglu, et al.Journal of Affective Disorders|December 3, 2014
Different patterns of manic/hypomanic symptoms in depression: A pilot modification of the hypomania checklist-32 to assess mixed depressionMiguel L Prieto, Eric A Youngstrom, Aysegul Ozerdem, et al.Bipolar Disorders|June 26, 2020
Cognitive remediation therapy for patients with bipolar disorder: A randomised proof-of-concept trialRebecca Strawbridge, Dimosthenis Tsapekos, John Hodsoll, et al.Journal of Affective Disorders|September 28, 2013
A multinational study to pilot the modified Hypomania Checklist (mHCL) in the assessment of mixed depressionKursat Altinbas, Aysegul Ozerdem, Miguel L Prieto, et al.Journal of Affective Disorders|July 17, 2024
Altered oxidative neurometabolic response to methylene blue in bipolar disorder revealed by quantitative neuroimagingAlfonso Russo, Balázs Örzsik, Nefize Yalin, et al.Harm Reduction Journal|December 31, 2025
US drug policy does not align with experts' rankings of drug harms: a multi-criteria decision analysisMichael Broman, Alan K Davis, Stacey Armstrong, et al.Pageof 3